Company intelligence / Profile preview

L.D. Collins & Co.

Richmond, Surrey, United Kingdom

Ownership: Private
Development stage: Other

Overview

L.D. Collins & Co. is a specialized pharmaceutical company based in the United Kingdom, primarily focused on women's health and reproductive medicine. The company is best known for its flagship product, Cyclogest, a progesterone-based treatment used for luteal phase support in assisted reproductive technology (ART), as well as for treating premenstrual syndrome and postnatal depression. In 2011, L.D. Collins was acquired by the Hungarian pharmaceutical company Gedeon Richter to strengthen its international gynecological portfolio. Today, the company operates as a subsidiary, contributing to the global distribution of hormonal therapies for obstetric and gynecological conditions.

Therapeutic areas: PsychiatryWomen's Health
Modalities: HormoneSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on L.D. Collins & Co..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on L.D. Collins & Co..

Explore the full profile